AstraZeneca PLC (LON:AZN) posted better-than-expected core income in the fourth quarter, thanks to strong demand for its cancer and rare disease therapies that helped make up for waning sales of its COVID-19 vaccine. Core earnings per share during the three…
UBS has no interest in buying fellow Swiss lender Credit Suisse, the bank’s Chairman Colm Kelleher said in a interview published on Saturday. The former Morgan Stanley (NYSE:MS) president said he was focused on organic growth rather than acquisitions and…
